Nilandron Pregnancy Warnings
There are insufficient animal toxicity data. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
This drug is not indicated for use in female patients.
AU TGA pregnancy category: Not assigned
US FDA pregnancy category: C
See references
